Cite
HARVARD Citation
Doan, Q. et al. (n.d.). Modeling the long-term efficacy of neratinib in the extended adjuvant setting for women with HER2+/HR+ early stage breast cancer (ESBC). Breast. pp. S19-S20. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Doan, Q. et al. (n.d.). Modeling the long-term efficacy of neratinib in the extended adjuvant setting for women with HER2+/HR+ early stage breast cancer (ESBC). Breast. pp. S19-S20. [Online].